ICICI Direct is bullish on GSK Consumer has recommended buy rating on the stock with a target price of Rs 8340 in its research report dated May 13, 2019.
ICICI Direct's research report on GSK Consumer
Net revenue for the quarter grew by 9.3% YoY to Rs 1,286.1 crore on the back of 6.5% volume growth. Benefitted by low input costs, especially milk prices, EBITDA margins increased by 357 bps to 24.8% primarily driven by 164 bps increase in gross margins and 357 bps decline in other overheads to sales, partly offset by 115 bps increase in employee expenses & 49 bps increase in marketing expenses to sales during the quarter. With higher operating profit and other income, PAT for the quarter increased by 35% YoY to Rs 285.8 crore. The company declared dividend of Rs 105/share. crore.
Outlook
Margins should be well supported by judicious price increases, mix accretive innovation and significant cost-reduction initiatives. We reiterate our BUY recommendation on the stock with a target price of Rs 8,340/share.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
